Publication:

Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu‐Natal

Loading...
Thumbnail Image

Date

2015

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

John Wiley and Sons Inc.
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Drain, PK, JM Kleene, SM Coleman, E Losina, JN Katz, J Giddy, D Ross, KA Freedberg, and IV Bassett. 2015. “Prevalence of cryptococcal antigenuria at initial HIV diagnosis in KwaZulu‐Natal.” HIV Medicine 16 (10): 640-644. doi:10.1111/hiv.12263. http://dx.doi.org/10.1111/hiv.12263.

Abstract

Objectives: The World Health Organization (WHO) recommends screening HIV‐infected people for cryptococcal antigens to identify cryptococcosis, a major cause of AIDS‐related deaths. As the burden of cryptococcosis is unknown in South Africa's KwaZulu‐Natal province, we assessed the cryptococcal antigenuria prevalence among newly diagnosed HIV‐infected adults there. Methods: We conducted a cross‐sectional study of newly diagnosed HIV‐infected adults who received voluntary HIV testing in an out‐patient clinic. Participants provided a urine specimen in a sterile container, and we performed testing with a WHO‐endorsed rapid cryptococcal antigen lateral flow assay (Immy Inc., Norman, OK, USA) per the manufacturer's specifications. We assessed cryptococcal antigenuria prevalence among participants with CD4 counts < 200 cells/μL, and stratified results by CD4 count categories. Results: Among 432 participants, the mean (± standard deviation) age was 36.1 ± 9.9 years and 172 (40%) were female. The overall estimated prevalence of cryptococcal antigenuria was 9.0% [95% confidence interval (CI) 6.5–12.1%]. CD4 counts were available for 319 participants (74%); the median CD4 count was 75 cells/μL [interquartile range (IQR) 34–129 cells/μL]. Participants with a negative cryptococcal antigenuria screening test had a median CD4 count of 79 cells/μL (IQR 36–129 cells/μL), while participants with a positive cryptococcal test had a median CD4 count of 41 cells/μL (IQR 10–112 cells/μL). The estimated prevalence of cryptococcal antigenuria among participants with CD4 counts < 50 cells/μL was 12.5% (95% CI 7.0–20.1%), which was significantly higher than that among participants with CD4 counts of 50–200 cells/μL (4.8%; 95% CI 2.3–8.7%). Conclusions: Nearly 1 in 10 newly diagnosed HIV‐infected adults with CD4 counts < 200 cells/μL in KwaZulu‐Natal had evidence of cryptococcal antigenuria. Point‐of‐care CD4 count testing and cryptococcal antigen screening may rapidly identify cryptococcosis at the time of HIV diagnosis.

Description

Research Data

Keywords

Short Communication, cryptococcal urine antigen, cryptococcosis, cryptococcus, diagnosis

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories